211 related articles for article (PubMed ID: 34449552)
1. The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids.
Rubisz P; Hirnle L; Kobierzycki C
Curr Issues Mol Biol; 2021 Jul; 43(2):802-817. PubMed ID: 34449552
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
Mozzachio K; Moore AB; Kissling GE; Dixon D
Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
[TBL] [Abstract][Full Text] [Related]
4. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
5. [The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].
Demura TA; Revazova ZV; Kogan EA; Adamyan LV
Arkh Patol; 2017; 79(3):19-26. PubMed ID: 28631712
[TBL] [Abstract][Full Text] [Related]
6. The Research of Feasibility and Efficacy of Radiofrequency Ablation in Treating Uterine Fibroids.
Luo X; Shu SR; Ma XF; Shuai HL
Medicine (Baltimore); 2015 Nov; 94(47):e1956. PubMed ID: 26632689
[TBL] [Abstract][Full Text] [Related]
7. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens.
Ichimura T; Kawamura N; Ito F; Shibata S; Minakuchi K; Tsujimura A; Umesaki N; Ogita S
Fertil Steril; 1998 Nov; 70(5):967-71. PubMed ID: 9806586
[TBL] [Abstract][Full Text] [Related]
10. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
11. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P
J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
Al-Hendy A; Diamond MP; El-Sohemy A; Halder SK
J Clin Endocrinol Metab; 2015 Apr; 100(4):E572-82. PubMed ID: 25625804
[TBL] [Abstract][Full Text] [Related]
13. Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.
Veronica M; Ali A; Venkateshwari A; Mamata D; Nallari P
Tumour Biol; 2016 Jun; 37(6):8067-74. PubMed ID: 26715264
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
15. Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas.
Plewka D; Marczyński J; Morek M; Bogunia E; Plewka A
Biomed Res Int; 2014; 2014():521313. PubMed ID: 25050358
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.
Giaginis C; Georgiadou M; Dimakopoulou K; Tsourouflis G; Gatzidou E; Kouraklis G; Theocharis S
Dig Dis Sci; 2009 Feb; 54(2):282-91. PubMed ID: 18465232
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
[TBL] [Abstract][Full Text] [Related]
18. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
Sun X; Mittal K
Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
